Book writer. Cat lover. Coffee fanatic. $tlhutchinson https://xitter.gq/t.co/AjiCTtDvtB
Joined May 2020
- Tweets1.6K
- Following789
- Followers817
- Likes3.8K
Pinned Tweet
If anyone in the #WritingCommmunity wants to get their book formatted with Vellum feel free to reach out to me, I offer formatting services, $110 for anything over 80k is the max and am willing to work out payment plans. #amwriting #writer #amwritingfiction #fantasy #writingtips
My debut novel Endering comes out tomorrow and quite frankly, I'm excited and terrified in every fathomable way.
#writer #writing #debutnovel #writingcommunity #indieauthor #publishedauthor
Hey @IngramSpark why can't people upload new files in the 'in progress' status, and why can't I fix the errors I have popping up? I'm just not allowed to access anything?
#amwriting #writer #writingtwitter #writerslift #writingcommunity
Tiffany Hutchinson retweeted
So when @msf, @pih, and hundreds of TB researchers and caregivers signed a letter begging you to end secondary patents for bedaquiline.... they were lying?
THAT'S your response?
It is false to suggest—as some recently have—that our patents are being used to prevent access to SIRTURO® (bedaquiline), our medicine for MDR-TB.
In fact, we have already entered into a collaboration with the Stop TB Partnership’s Global Drug Facility (“GDF”)—the largest procurer of TB medicines—which enables them to invite potential generic suppliers and purchase generic versions of SIRTURO® 100mg. On April 5, during a World Health Organization meeting, the GDF shared its intent to launch a tender for generic versions of SIRTURO® 100mg in the third quarter of 2023: social.jnj.com/3XSgjRZ
In addition, we have shipped more than 660,000 courses of SIRTURO® to 159 countries since launch. Our patents made this possible, enabling us to assist countries to scale-up their use of our medicine responsibly and sustainably and invest in multiple, critical, anti-TB efforts. For instance, in the face of rising drug resistance, we support stewardship efforts that ensure MDR-TB patients can benefit from our medicine today and in the future.
Unfortunately, the most significant barrier to treatment access for patients today is the fact that millions of patients with TB go undiagnosed every year. This is a challenge that we have invested significant resources to overcome and must all get behind if we are to achieve the global goal of ending TB.
Tiffany Hutchinson retweeted
Good morning. Johnson & Johnson has not yet commented on the huge public outcry over the last 24 hours about their pursuit of patent evergreening for bedaquiline, a medicine critically important to curing multidrug-resistant tuberculosis. Today is the day, @JNJGlobalHealth, to end the pursuit of an everlasting patent so that six million people can receive lifesaving medication over the next four years. #PatientsNotPatents
How about..... not being needlessly terrible and ending the bedaquiline patent? @JNJNews @JNJGlobalHealth
#PatientsNotPatents
@johngreen
Tiffany Hutchinson retweeted
I want to be very clear that no one is SUGGESTING that people will die because Johnson & Johnson is trying to immorally extend their patent on bedaquline an additional 4 years after its 20-year term.
Instead, people are STATING THE FACT that people will die because of Johnson & Johnson trying to immorally extend their patent on bedaquiline an additional 4 years after its 20-year term.
It is false to suggest—as some recently have—that our patents are being used to prevent access to SIRTURO® (bedaquiline), our medicine for MDR-TB.
In fact, we have already entered into a collaboration with the Stop TB Partnership’s Global Drug Facility (“GDF”)—the largest procurer of TB medicines—which enables them to invite potential generic suppliers and purchase generic versions of SIRTURO® 100mg. On April 5, during a World Health Organization meeting, the GDF shared its intent to launch a tender for generic versions of SIRTURO® 100mg in the third quarter of 2023: social.jnj.com/3XSgjRZ
In addition, we have shipped more than 660,000 courses of SIRTURO® to 159 countries since launch. Our patents made this possible, enabling us to assist countries to scale-up their use of our medicine responsibly and sustainably and invest in multiple, critical, anti-TB efforts. For instance, in the face of rising drug resistance, we support stewardship efforts that ensure MDR-TB patients can benefit from our medicine today and in the future.
Unfortunately, the most significant barrier to treatment access for patients today is the fact that millions of patients with TB go undiagnosed every year. This is a challenge that we have invested significant resources to overcome and must all get behind if we are to achieve the global goal of ending TB.
Why don't you stop being greedy fucking cowards? One day the 99% is going to eat you alive and I can't wait to see it. #PatientsNotPatents
It is false to suggest—as some recently have—that our patents are being used to prevent access to SIRTURO® (bedaquiline), our medicine for MDR-TB.
In fact, we have already entered into a collaboration with the Stop TB Partnership’s Global Drug Facility (“GDF”)—the largest procurer of TB medicines—which enables them to invite potential generic suppliers and purchase generic versions of SIRTURO® 100mg. On April 5, during a World Health Organization meeting, the GDF shared its intent to launch a tender for generic versions of SIRTURO® 100mg in the third quarter of 2023: social.jnj.com/3XSgjRZ
In addition, we have shipped more than 660,000 courses of SIRTURO® to 159 countries since launch. Our patents made this possible, enabling us to assist countries to scale-up their use of our medicine responsibly and sustainably and invest in multiple, critical, anti-TB efforts. For instance, in the face of rising drug resistance, we support stewardship efforts that ensure MDR-TB patients can benefit from our medicine today and in the future.
Unfortunately, the most significant barrier to treatment access for patients today is the fact that millions of patients with TB go undiagnosed every year. This is a challenge that we have invested significant resources to overcome and must all get behind if we are to achieve the global goal of ending TB.
#PatientsNotPatents because these rich mother fuckers forgot that us being civil was a compromise to ripping their doors down and beating them to death in front of their families. Let people live. #tuberculosis
Are you wondering what it looks like being a #Gemini rn? Its almost getting hit by a car almost hitting a deer and horse, waking up the horses owners, helpin keep the horse out of the road while they got it just to go home with a hurt foot and a tick in my hand all in the last hr
The fact that this atrocity is still not really being addressed is sickening.
#majidrezarahnavard #stopexecutionsiniran
My favorite thing about new writers is when they go 'haha writing a book wasnt that hard!'
mostly because they don't have any idea what comes next.
#amwritingfiction #amwriting
#WritingCommunity
#writers #writerslife
W.I.P Tidbit: Agrenon is the ONLY kingdom that has adopted a law allowing their Endering to leave if they want to.
#amwriting #writers #amwritingfiction #writerscafe #writingcommunity
Nugget there are two things you do after you realize you need to kill a character. First you cry. Then you plan out the most devastating death you can imagine. It's okay if that second part takes a bit.
#writingcommunity #amwriting #writer #amwritingfiction #plotting
I think you're doing pretty well considering you started with a bunch of blank pages.
#writers #amwriting #amwritingfiction #writingcommunity #writing #writerscafe
W.I.P Tidbit:
Photomyra have standards of beauty that rely on symmetry making them believe that any severe injury makes them less beautiful. This is not the case and Queen Saha helps end this stereotype.
#amwriting #writingcommunity #amwritingfiction #writer #writing
Hey Nugget, one of these days someone is going to look you dead in the eyes and tell you they can't wait to watch you fail. Succeed anyway.
#amwriting #writingcommunity #writer #writers #amwritingfiction